Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

Lung cancer is the leading cause of cancer-related death in the United States. Here, we evaluated the potential clinical utility of soluble human epidermal growth factor receptor 2 (sHER2) for the risk assessment, screening, and diagnosis of non-small cell lung cancer (NSCLC) using an unmatched case...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosentino-Boehm, Abby L., Lafky, Jacqueline M., Greenwood, Tammy M., Kimbler, Kimberly D., Buenafe, Marites C., Wang, Yuxia, Branscum, Adam J., Yang, Ping, Maihle, Nita J., Baron, Andre T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665577/
https://www.ncbi.nlm.nih.gov/pubmed/26835666
http://dx.doi.org/10.3390/diagnostics3010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665577/
https://www.ncbi.nlm.nih.gov/pubmed/26835666
http://dx.doi.org/10.3390/diagnostics3010013

Ejemplares similares